TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event

Breakout & Setup

Volume Surge

4 Hits · last calculated September 19, 2026 Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Market filter active: the list shows 4 hits from US

Methodology & criteria

Relative volume (20 days) ≥ 2 and daily change ≥ 3% — a clear volume surge with price movement.

Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) are excluded.

🔔 Watch scanner

Terms in This Scanner Explained

(14)
ADR (Average Daily Range)
The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Scanners that run without the global filters still include them; that is noted below their hit list. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
AI Classification
Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
Analysis (Full Company Analysis)
If the Analysis column shows "Read," there is an in-depth TickerGuard company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
Avg/Yr 3Y (Average Annual Return)
The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
Earnings Date
The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
EPS (Earnings per Share)
Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
Free Cash Flow (FCF)
Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
Funda Rating (Fundamental Rating A+ to F)
Our proprietary fundamental rating from 0 to 100 points with a school-grade rank from A+ to F. 50 points is the average across the universe, 100 the best possible score. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below — A/A+ are the fundamentally strongest stocks in the universe.
Market Capitalization (Mkt Cap)
The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run. The cap does not apply to scanners that run without the global filters; that is noted below their hit list.
Net Margin
How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
Operating Cash Flow (OCF)
The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
Piotroski F-Score
A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
Sector & Industry
Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
Stage (Weinstein Stages 1-4)
Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.

View all terms in the Scanner Glossary

Hit List

Filter

Rating (traffic light)

Stage

Funda Rating

Piotroski

Columns

This scanner's columns

Extra columns

Tip: clicking a column header sorts the table by that column; a second click flips the direction.

Volume Surge
Symbol Earnings Avg/Y 3Y Volatility Stage Funda Rating Piotroski MktCap Industry AI Rating Deep Dive Deep-Dive Report Sector Price YTD 6 Mo. 1 Year Off High Price Target RS EPS Rating ADR 10D ADR 30D Beta P/E P/E (f) P/S P/B P/FCF PEG EV/EBITDA EBIT Margin Gross Margin Net Margin ROE ROA Debt/Eq Equity Ratio Sales +/Y Growth Score Div. Yield Payout Ratio Altman Z Inst. % Short % Analysts
FDMT 4D Molecular Therapeutics Inc 08/10 -22 % 80 % Stage 3 C 49 4 of 9 0.8 $ Biotechnology – — — Healthcare 15.20 $ +54.7 % +59.0 % +120.4 % −6.7 % +107.2 % 89 50 10.5 % 8.5 % 2.73 — 0.0 8.7 2.1 — — -3.6 — -157.7 % -194.7 % -34.9 % -25.1 % 0.05 — +230,194.6 % 6 0.0 % 0.0 % 8.4 98.4 % 25.1 % 4.0 (12)
USIO Usio Inc 08/05 +5 % 57 % Stage 2 C 52 8 of 9 0.1 $ Software - Infrastructure – — — Technology 2.40 $ +45.6 % +66.9 % +55.5 % −3.6 % +168.9 % 84 11 7.2 % 7.4 % 1.35 — 158.7 0.8 4.0 — 0.95 83.4 — 22.3 % -1.6 % -11.6 % -0.6 % 0.20 — +3.0 % 5 0.0 % 0.0 % 1.9 25.0 % 0.3 % 4.0 (5)
GALT Galectin Therapeutics Inc 08/13 +39 % ⚠ Wildest 10% 93 % Stage 4 D 33 5 of 9 0.3 $ Biotechnology – — — Healthcare 3.90 $ -25.0 % +23.3 % -19.2 % −40.7 % +197.3 % 25 42 14.5 % 10.6 % 0.39 — 4.5 — 191.5 — — -4.0 — — 0.0 % -3,728.0 % -64.2 % -1.04 — — 3 0.0 % 0.0 % -90.0 21.2 % 11.8 % 5.0 (1)
GAIA Gaia Inc 08/10 -1 % 73 % Stage 4 D 41 4 of 9 0.0 $ Entertainment – — — Communication Services 1.30 $ -34.2 % -42.7 % -78.4 % −64.5 % +198.1 % 6 4 7.4 % 6.2 % 0.96 — 138.9 0.3 0.4 — 1.23 3.4 — 86.3 % -6.1 % -5.5 % -2.8 % 0.17 — +9.5 % 6 0.0 % 0.0 % 2.0 55.2 % 1.1 % 5.0 (3)

Price Chart

Quarterly Figures

No quarterly data available.

Frequently Asked Questions

Relative volume (20 days) ≥ 2 and daily change ≥ 3% — a clear volume surge with price movement.

All scanners are recalculated daily across the entire stock universe — most recently on September 19, 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).

Currently, 4 stocks pass this scanner's criteria (as of September 19, 2026).

Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) are excluded.

Related scanners

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?